| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 5 Dec 24 | RXRX Recursion Pharmaceuticals | Class A Common Stock | Sell | Dispose S | No | Yes | 7.12 | 20,000 | 142.40 k | 736,633 |
| 5 Dec 24 | RXRX Recursion Pharmaceuticals | Class A Common Stock | Conversion | Acquire C | No | No | 0 | 20,000 | 0.00 | 756,633 |
| 5 Dec 24 | RXRX Recursion Pharmaceuticals | Class B Common Stock Class A Common Stock | Conversion | Dispose C | No | No | 0 | 20,000 | 0.00 | 6,016,700 |
| 4 Dec 24 | RXRX Recursion Pharmaceuticals | Class A Common Stock | Sell | Dispose S | No | Yes | 7.16 | 20,000 | 143.20 k | 736,633 |
| 4 Dec 24 | RXRX Recursion Pharmaceuticals | Class A Common Stock | Conversion | Acquire C | No | No | 0 | 20,000 | 0.00 | 756,633 |
| 4 Dec 24 | RXRX Recursion Pharmaceuticals | Class B Common Stock Class A Common Stock | Conversion | Dispose C | No | No | 0 | 20,000 | 0.00 | 6,036,700 |
| 15 Nov 24 | RXRX Recursion Pharmaceuticals | Class A Common Stock | Payment of exercise | Dispose F | No | No | 6.175 | 26,023 | 160.69 k | 736,633 |
| 14 Nov 24 | RXRX Recursion Pharmaceuticals | Class A Common Stock | Sell | Dispose S | No | Yes | 7.35 | 20,000 | 147.00 k | 762,656 |
| 14 Nov 24 | RXRX Recursion Pharmaceuticals | Class A Common Stock | Conversion | Acquire C | No | No | 0 | 20,000 | 0.00 | 782,656 |
| 14 Nov 24 | RXRX Recursion Pharmaceuticals | Class B Common Stock Class A Common Stock | Conversion | Dispose C | No | No | 0 | 20,000 | 0.00 | 6,056,700 |
